Real‐world treatment patterns and outcomes in non‐transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom-Reference-Cited by-同舟云学术

Real‐world treatment patterns and outcomes in non‐transplant newly diagnosed multiple Myeloma in France, Germany, Italy, and the United Kingdom

Published:2020-06-09 Issue:3 Volume:105 Page:308-325
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Mohty Mohamad¹^ORCID,Knauf Wolfgang²,Romanus Dorothy³,Corman Shelby⁴^ORCID,Verleger Katharina⁵,Kwon Youngmin⁴,Cherepanov Dasha³,Cambron‐Mellott M. Janelle⁶,Vikis Haris G.⁶,Gonzalez Francisco⁷,Gavini Francois⁷,Ramasamy Karthik⁸

Affiliation:

1. Hôpital Saint‐Antoine Service d'Hématologie Clinique et de Thérapie Cellulaire Sorbonne University Paris France

2. Center for Hematology and Oncology Agaplesion Bethanien Hospital Frankfurt am Main Germany

3. Global Outcomes Research and Epidemiology Millennium Pharmaceuticals, Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited Cambridge MA USA

4. Pharmerit International Bethesda MD USA

5. Pharmerit International Berlin Germany

6. Kantar Health New York NY USA

7. Takeda Pharmaceuticals International AG Zurich Switzerland

8. Department of Clinical Haematology Oxford University Hospitals Oxford UK

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13439

Reference46 articles.